News and Events

Read about new IDEXX products and services, joint ventures, educational events and business acquisitions.

Our dedication to research and development results in frequent product improvements and innovations, so check back often.

Investors
Press Releases:

View all press releases

January 29

IDEXX Laboratories Announces Fourth Quarter and Full Year Results
WESTBROOK, Maine, January 20, 2010—IDEXX Laboratories, Inc. (NASDAQ: IDXX), today reported that revenues for the fourth quarter of 2009 increased 11% to $270.3 million, from $243.3 million for the fourth quarter of 2008. Organic revenue growth, as defined below, was 6%. Earnings per diluted share ("EPS") for the quarter ended December 31, 2009 were $0.51, compared to $0.39 for the same period in the prior year. EPS grew 16% when compared to fourth quarter 2008 non-GAAP EPS, which adjusted EPS for the 2008 disposition of the pharmaceutical product lines and related restructuring.

January 20

IDEXX Laboratories to Release 2009 Fourth Quarter and Full-Year Financial Results
WESTBROOK, Maine, January 20, 2010—IDEXX Laboratories, Inc. (NASDAQ: IDXX), has scheduled the release of its 2009 fourth quarter and full-year financial results for Friday, January 29, at approximately 7:00 a.m. (eastern). The Company will conduct a conference call beginning at 9:00 a.m. (eastern) on that day.

January 15

IDEXX Exceeds Catalyst Dx® Chemistry Analyzer 2009 Placement Goal and Grows IDEXX SmartService™ Solutions Customer Base [Trade]
WESTBROOK, Maine, January 15, 2010—IDEXX Laboratories, Inc. announced it placed over 2,000 Catalyst Dx® Chemistry Analyzers in veterinary practices worldwide in 2009, exceeding the original goal for the year. The total installed base has grown to nearly 2,800 since the analyzer was first introduced in March 2008. The Catalyst Dx analyzer, a next-generation chemistry instrument, is the newest addition to the IDEXX VetLab® integrated suite of in-house analyzers. Veterinary practices can significantly expand the range and capability of their in-house diagnostic laboratories with the Catalyst Dx analyzer, while substantially increasing work-flow efficiencies.